Danni Wu, Ph.D.

I am a statistician at Pfizer.

Before Pfizer, I was a postdoctoral research associate at Harvard University and earned my Ph.D. in Biostatistics at New York University.

Danni Wu

Research interests

Bayesian adaptive design Bayesian hierarchical modeling Causal inference Statistical computing

Experience

  • 2025 — present
    Pfizer · Manager, Statistics · South San Francisco

    Lead study statistican for oncology trials. Developed a Bayesian framework for early efficacy detection.

  • 2024 — 2025
    Harvard University · Postdoctoral Research Associate · Boston

    Led analyses comparing dolutegravir- and efavirenz-based treatment on postpartum depression, and worked on the development of an augmented trial design combining randomized and observational data.

  • 2019 — 2024
    New York University · Ph.D. · New York

    Developed a Bayesian adaptive design for a 2,369-patient prospective meta-analysis that informed FDA policy on COVID-19 convalescent plasma.

  • 2023
    Moderna · Statistics & Programming Intern, Oncology · Boston

    Designed a Bayesian adaptive framework with surrogate endpoints for mRNA personalized cancer vaccine.

Education

  • 2019 — 2024
    New York University · Ph.D. in Biostatistics

    Dissertation: Developing Bayesian Hierarchical Models for Advancing Analysis in Clinical Trials.

  • 2017 — 2018
    Cornell University · M.S. in Biostatistics and Data Science
  • 2013 — 2017
    Central University of Finance and Economics · B.S. in Applied Statistics, First Class Honors

Selected talks

  • 2026
    Society for Clinical Trials · Invited talk
  • 2025
    Pfizer Global Statistics Conference · Best Poster Award
  • 2025
    Joint Statistical Meetings (JSM) · Contributed talk
  • 2024
    Harvard HIV Working Group Seminar · Invited talk
  • 2022
    ENAR Spring Meeting · Invited talk